BSE filing, BSE: 540204. Summary written from the filing by ALFA Finder's alert engine.
Eiko Lifesciences Ltd: key numbers
- Share price
- ₹50.72
- Market cap
- ₹69.59 Cr
- Revenue (annual)
- ₹52.57 Cr
- Net profit (annual)
- ₹4.50 Cr
- P/E (TTM)
- 14.2×Sector 34.1×
- Promoter holding
- 39.96%+0.05% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Eiko Lifesciences Ltd
All →Eiko Lifesciences Convertible Warrants
Eiko Lifesciences allotted 1,50,000 equity shares upon conversion of warrants, receiving a balance payment of Rs. 0.62 Crore from promoter Lenus Finvest Private Limited.
- Value
- ₹0.62 Cr
- From
- Lenus Finvest Private Limited
Eiko Lifesciences Other Announcement
The company submitted the Regulation 74(5) compliance certificate from its Registrar and Share Transfer Agent for the quarter ended September 30, 2026.
Eiko Lifesciences Annual General Meeting
Eiko LifeSciences held its 49th Annual General Meeting on September 22, 2026. The meeting transacted business, including adoption of financial statements and appointment of directors.
Eiko Lifesciences Other Announcement
Eiko Lifesciences informed exchanges that it sent the AGM notice and Annual Report weblink to shareholders who have not registered email addresses.
Eiko Lifesciences Annual General Meeting
Eiko Lifesciences Limited has issued a notice for its 49th Annual General Meeting scheduled for September 22, 2026, to discuss financial statements and related matters.
- Value
- ₹252.3 Cr
Eiko Lifesciences Annual Report
Eiko Lifesciences Limited has announced its 49th Annual General Meeting, scheduled for September 22, 2026. The company has also filed its Annual Report for FY 2025-26.
Other debt & borrowing announcements
All →Signatureglobal (India) Debt & Borrowing
Signatureglobal disclosed corporate guarantees issued by its wholly owned subsidiaries to IndusInd Bank facilities. The guarantees secure Rs 150 crore, Rs 250 crore and Rs 398.3 crore of term loan facilities.
LIC Housing Finance Debt & Borrowing
LIC Housing Finance reported a 1.24x security cover on listed secured NCDs. It is a Regulation 54 certificate with no new event amount.
Religare Enterprises Debt & Borrowing: ₹150 Cr
Care Health Insurance, a material subsidiary of Religare, allotted listed subordinated debentures worth ₹150 Crore at a 10.50% coupon. The debentures mature in 2036, callable after five years.
- Value
- ₹150.0 Cr
Blue Coast Hotels Debt & Borrowing: ₹14.52 Cr
Blue Coast Hotels defaulted on Rs 14.52 crore principal and dividend on redeemable preference shares. Default occurred 30 October 2026, affecting unlisted debt holders.
- Value
- ₹14.52 Cr
Sammaan Capital Debt & Borrowing: ₹0.88 Cr
Sammaan Capital paid Rs.0.88 Crore of monthly interest on secured NCDs on October 30, 2026, ahead of the November 1 due date.
- Value
- ₹0.88 Cr
Sammaan Capital Debt & Borrowing: ₹0.58 Cr
Sammaan Capital certifies timely payment of Rs 0.58 crore interest on listed public-issue NCDs. The payment covers seven ISINs, with interest paid on October 30, 2026.
- Value
- ₹0.58 Cr